Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Associations of Serum Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Colorectal Cancer Risk Doratha Byrd Moffitt Cancer Center PLCO Dec 27, 2019 2019-1004
Instrumental variable methods in survival outcome Youjin Lee University of Pennsylvania PLCO Dec 16, 2019 PLCO-561
Blood metabolomics, smoking and lung cancer risk Wei Jie Seow National University of Singapore PLCO Dec 16, 2019 PLCO-558
Analyses using GWAS data from PLCO to evaluate genetic impact on colorectal screening and outcomes Wen-Yi Huang National Cancer Institute PLCO Dec 11, 2019 PLCO-560
Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Guo-Chao Zhong The Second Affiliated Hospital of Chongqing Medical University PLCO Dec 11, 2019 PLCO-559
Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men Burcu Darst University of Southern California PLCO Nov 26, 2019 PLCO-555
Associations of Dietary Inflammatory and Insulinemic Potential with Risk of Cancer Development Fred Tabung The Ohio State University College of Medicine PLCO Nov 25, 2019 PLCO-553
Association of endogenous estrogens, estrogen metabolites, androgens and androgen metabolites with Ovarian Cancer Britton Trabert NIH PLCO Nov 21, 2019 2016-0047
Drinking and pre-diagnosed BMI trajectories and their impact on the mortality of upper-gastrointestinal cancers in the PLCO population. Jianjun Li Sun Yat-Sen University Caner Center PLCO Nov 13, 2019 PLCO-546
Machine Learning Application of Cancer Data Analysis Mochen Li Purdue University PLCO Nov 13, 2019 PLCO-552
Incorporating Biomarkers to Improve Lung Cancer Risk Prediction Samir Hanash University of Texas at MD Anderson PLCO Nov 4, 2019 PLCO-549
Dietary Inflammatory Index and risk of differentiated thyroid cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Li Chen Department of the Endocrine and Breast Surgery, The First Affiliated hospital of Chongqing Medical university PLCO Oct 24, 2019 PLCO-543
Machine Learning to select patients benefiting from prostate cancer screening Jean-Emmanuel Bibault Laboratory of Artificial Intelligence in Medicine and Biomedical Physics, Stanford University PLCO Oct 24, 2019 PLCO-541
Predicting Cancer diagnosis based on preliminary screenings Jonathan Mendoza Independent PLCO Oct 24, 2019 PLCO-532
Evaluation of Patients Data using AI techniques and It's Application in Pancreatic Cancer Differential Diagnosis Wanessa Sena Federal Institute of Pernambuco PLCO Oct 10, 2019 PLCO-539
Link-based survival additive models with mixed types of censoring. Giampiero Marra University College London PLCO Oct 8, 2019 PLCO-538
Inflammatory potential of diet and risk of ovarian cancer by menopausal status in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Zhuyue Li West China Hospital PLCO Oct 8, 2019 PLCO-536
“Development of a probabilistic network for clinical pathways based on patient cohort characteristics, outcome-indicators and clinical workflow analysis to create artificial patients with prostatic adenocarcinoma” Andrea Riedel Institute for general practitioners PLCO Oct 8, 2019 PLCO-535
Tobacco smoking is associated with increased tumor grade and stage and grade along with the mucinous carcinoma histopathologic type. Rodger Rothenberger University of Cincinnati PLCO Oct 3, 2019 PLCO-534
A Comparison Between Multi Classification Algorithms on PLCO Colorectal Cancer Dataset Bawer Berwary Van Yuzuncu Yil University PLCO Oct 3, 2019 PLCO-533